INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2013

Oral limonene accumulated in breast tissue and reduced tumor cyclin D1 expression.

Forty-three women with newly diagnosed operable breast cancer took 2 grams of limonene daily for 2 to 6 weeks before surgical resection. Limonene preferentially concentrated in breast tissue, reaching a mean level of 41.3 µg/g, and led to a 22% reduction in tumor cyclin D1 expression (p = 0.002). Circulating IGF-I increased slightly, while tissue Ki67, cleaved caspase-3, leptin, adiponectin, and IL-6 showed no significant alterations.

Study type
Open-label clinical trial
Who was studied
43 women with newly diagnosed operable breast cancer
What was measured
Breast tissue limonene concentration and tumor biomarker expression

THE PAPER

Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer.

Miller JA, Lang JE, Ley M, Nagle R, Hsu CH, Thompson PA, Cordova C, Waer A, Chow HH. Cancer Prev Res (Phila), 2013.

PubMed 23554130 ↗DOI 10.1158/1940-6207.CAPR-12-0452 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.